核子醫學市場：按類型、應用程式、最終用戶和地區分類

Nuclear Medicine Market, By Type, By Application, By End User, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2026年，核醫市場規模將達204億美元，2033年將達到434.5億美元。預計從2026年到2033年，該市場將以11.4%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	204億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.40%	2033年市場規模預測：	434.5億美元

近年來，受慢性病患病率上升、核醫學技術進步以及個人化醫療需求日益成長的推動，全球核醫學市場經歷了顯著成長。核子醫學利用放射性物質進行診斷和治療，能夠早期發現和治療包括癌症、心血管疾病和神經系統疾病在內的多種疾病。該市場涵蓋廣泛的產品和服務，包括放射性藥物、影像設備和軟體解決方案，滿足全球醫療專業人員和患者的多樣化需求。隨著醫療產業的不斷發展和創新技術的融合，預計未來幾年核醫市場將進一步擴張和發展。

市場動態

全球核子醫學市場受多種關鍵促進因素、限制因素和機會的影響。其中一個主要促進因素是癌症和心血管疾病等慢性疾病發生率的上升，這些疾病需要先進的診斷和治療性介入。此外，全球人口老化預計將推動對核醫學影像的需求，因為老年人更容易患上與老齡化相關的疾病。混合成像技術的開發和新型放射性藥物的引入等技術進步，也透過提高核醫學成像的準確性和效率來推動市場成長。然而，該市場也面臨一些限制因素，包括核醫設備的高成本以及放射性藥物核准和使用方面的嚴格監管要求。核子醫學技術領域訓練有素的專業人員短缺也對市場成長構成挑戰。儘管有這些限制因素，核醫市場仍蘊藏著巨大的成長機會，尤其是在對先進醫療服務需求不斷成長的新興經濟體。核子醫學在阿茲海默症和帕金森氏症等神經系統疾病的診斷和治療中日益普及，這為市場擴張提供了另一個有希望的機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球核醫學市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球核子醫學市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
透過分析全球核子醫學市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第8章競爭情勢

Siemens Healthineers
GE Healthcare
Philips Healthcare
Toshiba Medical Systems
Bracco Imaging
Canon Medical Systems
EczacA+-baAYA+--Monrol
Mallinckrodt Pharmaceuticals
Lantheus Medical Imaging
Bayer AG
RadioMedix
IBA Radiopharma Solutions
Nordion（a Sotera Health company）
Advanced Accelerator Applications
Actinium Pharmaceuticals

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8016

Nuclear Medicine Market is estimated to be valued at USD 20.40 Bn in 2026 and is expected to reach USD 43.45 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 20.40 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.40%	2033 Value Projection:	USD 43.45 Bn

The global nuclear medicine market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases, advancements in nuclear medicine technology, and the growing demand for personalized medicine. Nuclear medicine involves the use of radioactive substances for diagnostic and therapeutic purposes, enabling the early detection and treatment of various diseases, including cancer, cardiovascular disorders, and neurological conditions. The market encompasses a wide range of products and services, such as radiopharmaceuticals, imaging equipment, and software solutions, catering to the diverse needs of healthcare professionals and patients worldwide. As the healthcare industry continues to evolve and embrace innovative technologies, the nuclear medicine market is poised for further expansion and development in the coming years.

Market Dynamic

The global nuclear medicine market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the rising incidence of chronic diseases, such as cancer and cardiovascular disorders, which require advanced diagnostic and therapeutic interventions. Additionally, the growing geriatric population worldwide is expected to fuel the demand for nuclear medicine procedures, as older individuals are more susceptible to age-related diseases. Technological advancements, including the development of hybrid imaging modalities and the introduction of novel radiopharmaceuticals, are also driving market growth by improving the accuracy and efficiency of nuclear medicine procedures. However, the market faces certain restraints, such as the high cost of nuclear medicine equipment and the stringent regulatory requirements for the approval and use of radiopharmaceuticals. The shortage of skilled professionals trained in nuclear medicine techniques also poses a challenge to market growth. Despite these restraints, the nuclear medicine market presents significant opportunities for growth, particularly in emerging economies, where there is a rising demand for advanced healthcare services. The increasing adoption of nuclear medicine in the diagnosis and treatment of neurological disorders, such as Alzheimer's and Parkinson's disease, is another promising opportunity for market expansion.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global nuclear medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Toshiba Medical Systems, Bracco Imaging, Canon Medical Systems, EczacA+-baAYA+--Monrol, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging, Bayer AG, RadioMedix, IBA Radiopharma Solutions, Nordion (a Sotera Health company), Advanced Accelerator Applications, and Actinium Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global nuclear medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nuclear medicine market

Market Segmentation

Type Insights (Revenue, USD Bn, 2021 - 2033)
Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
  - Tc-99m
  - I-123
  - Tl-201
  - Ga-67
  - Other SPECT Isotopes
- PET Radiopharmaceuticals
  - F-18
  - Rb-82
  - Other PET Isotopes
- Therapeutic Nuclear Medicine
  - Alpha Emitters
    - Ra-223
  - Beta Emitters
  - I-131
  - Y-90
  - Sm-153
  - Lu-177
  - Re-186
  - Other Beta Emitters
Brachytherapy Isotopes
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Others
Application Insights (Revenue, USD Bn, 2021 - 2033)
Oncology
Cardiology
Neurology
Endocrinology
Bone Metastasis
Gastroenterology
Pulmonology
Infectious Diseases
Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals & Clinics
Diagnostic Centers
Research Laboratories
Academic Institutions
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Siemens Healthineers
GE Healthcare
Philips Healthcare
Toshiba Medical Systems
Bracco Imaging
Canon Medical Systems
EczacA+-baAYA+--Monrol
Mallinckrodt Pharmaceuticals
Lantheus Medical Imaging
Bayer AG
RadioMedix
IBA Radiopharma Solutions
Nordion (a Sotera Health company)
Advanced Accelerator Applications
Actinium Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Nuclear Medicine Market, By Type
- Global Nuclear Medicine Market, By Application
- Global Nuclear Medicine Market, By End User
- Global Nuclear Medicine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Nuclear Medicine Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Diagnostic Nuclear Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - SPECT Radiopharmaceuticals
    - Tc-99m
    - I-123
    - Tl-201
    - Ga-67
    - Other SPECT Isotopes
  - PET Radiopharmaceuticals
    - F-18
    - Rb-82
Therapeutic Nuclear Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Alpha Emitters
    - Ra-223
  - Beta Emitters
    - I-131
    - Y-90
    - Sm-153
    - Lu-177
    - Re-186
    - Other Beta Emitters
  - Brachytherapy Isotopes
    - Cesium-131
    - Iodine-125
    - Palladium-103
    - Iridium-192
    - Others

5. Global Nuclear Medicine Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Bone Metastasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Gastroenterology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Pulmonology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Nuclear Medicine Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Nuclear Medicine Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Toshiba Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bracco Imaging
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Canon Medical Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
EczacA+-baAYA+--Monrol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lantheus Medical Imaging
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
RadioMedix
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
IBA Radiopharma Solutions
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nordion (a Sotera Health company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Advanced Accelerator Applications
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Actinium Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies